[Federal Register: August 17, 2009 (Volume 74, Number 157)]
[Proposed Rules]
[Page 41361-41362]
[DOCID:fr17au09-11]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 300

[EPA-HQ-SFUND-2009-0227; FRL-8945-2]

National Oil and Hazardous Substance Pollution Contingency Plan;
National Priorities List

AGENCY: Environmental Protection Agency.

ACTION: Notice of Intent To Delete the Island Chemical Corp/Virgin
Islands Chemical Corp. Superfund Site From the National Priorities
List.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) Region 2 is issuing
a Notice of Intent to Delete the Island Chemical Corp/Virgin Islands
Chemical Corp. (Site) located in St. Croix, Virgin Islands, from the
National Priorities List (NPL) and requests public comments on this
proposed action. The NPL, promulgated pursuant to section 105 of the
Comprehensive Environmental Response, Compensation, and Liability Act
(CERCLA) of 1980, as amended, is an appendix of the National Oil and
Hazardous Substances Pollution Contingency Plan (NCP). The EPA and the
Territory of U.S.Virgin Islands, through the Virgin Islands Department
of Planning and Natural Resources have determined that all appropriate
response actions under CERCLA, have been completed. However, this
deletion does not preclude future actions under Superfund.

DATES: Comments must be received by September 16, 2009.

ADDRESSES: Submit your comments, identified by Docket ID no. EPA-HQ-
SFUND-2009-0227, by one of the following methods:
     http://www.regulations.gov. Follow on-line instructions
for submitting comments.
     E-mail<EMAIL_ADDRESS>     Fax:<PHONE_NUMBER>.
     Mail: U.S. Environmental Protection Agency, Region 2, 290
Broadway, 20th floor, New York, NY 10007-1866.
     Hand delivery: U.S. Environmental Protection Agency,
Region 2, 290 Broadway, 20th floor, New York, NY. Such deliveries are
only accepted during the Docket's normal hours of operation, and
special arrangements should be made for deliveries of boxed
information.
    Instructions: Direct your comments to Docket ID no. EPA-HQ-SFUND-
2009-0227. EPA's policy is that all comments received will be included
in the public docket without change and may be made available online at
http://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through http://
www.regulations.gov or e-mail. The http://www.regulations.gov Web site
is an ``anonymous access'' system, which means EPA will not know your
identity or contact information unless you provide it in the body of
your comment. If you send an e-mail comment directly to EPA without
going through http://www.regulations.gov, your e-mail address will be
automatically captured and included as part of the comment that is
placed in the public docket and made available on the Internet. If you
submit an electronic comment, EPA recommends that you include your name
and other contact information in the body of your comment and with any
disk or CD-ROM you submit. If EPA cannot read your comment due to
technical difficulties and cannot contact you for clarification, EPA
may not be able to consider your comment. Electronic files should avoid
the use of special characters, any form of encryption, and be free of
any defects or viruses.
    Docket: All documents in the docket are listed in the http://
www.regulations.gov index. Although listed in the index, some
information is not publicly available, e.g., CBI or other information
whose disclosure is restricted by statue. Certain other material, such
as copyrighted material, will be publicly available only in the hard
copy. Publicly available docket materials are available either
electronically in http://www.regulations.gov or in hard copy at:

U.S. Environmental Protection Agency, Region 2, 290 Broadway,
Superfund, Record Center, Room 1828, New York, NY 10007-1866. Hours:
Monday to Friday from 9 a.m. to 5 p.m. Telephone No.<PHONE_NUMBER>
Department of Planning and Natural Resources, 45 Mars Hill,
Frederiksted, U.S. Virgin Islands, 00850. Hours: Monday to Friday from
9 a.m. to 5 p.m. Telephone No.<PHONE_NUMBER>.
U.S. Environmental Protection Agency, Caribbean Environmental
Protection Division, Tunick Building, Suite 102, 1336 Beltjen Road, St.
Thomas, VI 00801. Hours: Monday to Friday from 9 a.m. to 5 p.m.
Telephone No.<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Ms. Caroline Kwan, Remedial Project
Manager, U.S. Environmental Protection Agency, Region 2, 290 Broadway,
20th floor, New York, NY 10007-1866,<PHONE_NUMBER>, e-mail:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In the ``Rules and Regulations'' Section of
today's Federal Register, we are publishing a direct final Notice of
Deletion of Island Chemical Corp/Virgin Islands Chemical Corp. Site
without prior Notice of Intent to Delete because we view this as a
noncontroversial revision and anticipate no adverse comment. We have
explained our reasons for this deletion in the preamble to the direct
final Notice of Deletion, and those reasons are incorporated herein. If
we receive no adverse comment(s) on this deletion action, we will not
take further action on this Notice of Intent to Delete. If we receive
adverse comment(s), we will withdraw the direct final Notice of
Deletion, and it will not take effect. We will, as appropriate, address
all public comments in a subsequent final Notice of Deletion based on
this Notice of Intent to Delete. We will not institute a second comment
period on this Notice of Intent to Delete. Any parties interested in
commenting must do so at this time.
    For additional information, see the direct final Notice of Deletion
which is located in the Rules section of this Federal Register.

List of Subjects in 40 CFR Part 300

    Environmental protection, Air pollution control, Chemicals,
Hazardous waste, Hazardous substances, Intergovernmental relations,
Penalties, Reporting and recordkeeping requirements, Superfund, Water
pollution control, Water supply.

    Authority: 33 U.S.C. 1321(c)(2); 42 U.S.C. 9601-9657; E.O.
12777, 56 FR 54757, 3 CFR, 1991 Comp., p. 351; E.O. 12580, 52 FR
2923; 3 CFR, 1987 Comp., p. 193.

    Dated: August 3, 2009.
George Pavlou,
Acting Regional Administrator, Region 2.
[FR Doc. E9-19509 Filed 8-14-09; 8:45 am]

BILLING CODE 6560-50-P


[Federal Register Volume 80, Number 211 (Monday, November 2, 2015)]
[Notices]
[Pages 67411-67412]
[FR Doc No: 2015-27818]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-D-3787]

Information To Support a Claim of Electromagnetic Compatibility
of Electrically Powered Medical Devices; Draft Guidance for Industry
and Food and Drug Administration Staff; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the availability of the draft guidance entitled ``Information to
Support a Claim of Electromagnetic Compatibility (EMC) of Electrically-
Powered Medical Devices.'' This guidance describes the types of
information that should be provided to support a claim of
electromagnetic compatibility (EMC) in a premarket submission for an
electrically powered medical device. Electromagnetic disturbance is
electronic product radiation that may interfere with the performance of
an electrically powered medical device in its intended environment
(i.e., cause an electromagnetic interference (EMI)). EMC assessment
helps to ensure that a device is able to function in its intended
environment without introducing excessive electromagnetic disturbances
that might interfere with other devices. This draft guidance is not
final nor is it in effect at this time.

DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency considers your comment of this
draft guidance before it begins work on the final version of the
guidance, submit either electronic or written comments on the draft
guidance by December 17, 2015.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2015-D-3787 for ``Information to Support a Claim of Electromagnetic
Compatibility (EMC) of Electrically-Powered Medical Devices.'' Received
comments will be placed in the docket and, except for those submitted
as ``Confidential Submissions,'' publicly viewable at http://www.regulations.gov or at the Division of Dockets Management between 9
a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION''. The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on http://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
    An electronic copy of the guidance document is available for
download from the Internet. See the SUPPLEMENTARY INFORMATION section
for information on electronic access to the guidance. Submit written
requests for a single hard copy of the draft guidance document entitled
``Information to Support a Claim of Electromagnetic Compatibility (EMC)
of Electrically-Powered Medical Devices'' to the Office of the Center
Director, Guidance and Policy Development, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 5431, Silver Spring, MD 20993-0002. Send one self-
addressed adhesive label to assist that office in processing your
request.

FOR FURTHER INFORMATION CONTACT: Donald Witters, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave. Bldg. 62, Rm. 1130, Silver Spring, MD 20993-0002,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a draft guidance to provide
FDA's current thinking on the types of information that should be
provided in a premarket submission to support a claim of
electromagnetic compatibility for an electrically powered medical
device. EMI is a hazard with associated risk for electrically powered
medical devices. EMC assessment can help to ensure that the risks
associated with performance degradation of electrically powered medical
devices due to EMI are adequately mitigated.
    The draft guidance includes information consistent with
specifications described in FDA-recognized consensus national or
international standards for EMC such as in the International
Electrotechnical Commission (IEC) 60601-1-2: Edition 3: 2007-03,
Medical Electrical Equipment--Part 1-2: General Requirements for Basic
Safety and Essential Performance--Collateral Standard: Electromagnetic
Compatibility--Requirements and Tests; IEC 60601-1-2: Edition 4.0:
2014-01, Medical Electrical Equipment, Part 1-2: General Requirements
for Basic Safety and Essential Performance--Collateral Standard:
Electromagnetic Disturbances--Requirements and Tests; Association for
the Advancement of Medical Instrumentation (AAMI)/American National
Standards Institute (ANSI)/IEC 60601-1-2: 2007/(R) 2012 Medical
Electrical Equipment--Part 1-2: General Requirements for Basic Safety
and Essential Performance--Collateral Standard: Electromagnetic
Compatibility--Requirements and Tests; and AAMI/ANSI/IEC 60601-1-2:
2014, Medical Electrical Equipment--Part 1-2: General Requirements for
Basic Safety and Essential Performance--Collateral Standard:
Electromagnetic Disturbances--Requirements and Tests Standards that
sponsors and manufacturers of electrically powered medical devices
often reference. This draft guidance is intended to help ensure that
clear and consistent information is provided in premarket submissions
regarding medical device EMC and to facilitate the review of
submissions with EMC claims.

II. Significance of Guidance

    This draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent the current thinking of FDA on information
that should be provided to support claims of electromagnetic
compatibility of electrically powered medical devices. It does not
establish any rights for any person and is not binding on FDA or the
public. You can use an alternative approach if it satisfies the
requirements of the applicable statute and regulations.

III. Electronic Access

    Persons interested in obtaining a copy of the draft guidance may do
so by downloading an electronic copy from the Internet. A search
capability for all Center for Devices and Radiological Health guidance
documents is available at http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm. Guidance
documents are also available at http://www.regulations.gov. Persons
unable to download an electronic copy of ``Information to Support a
Claim of Electromagnetic Compatibility (EMC) of Electrically-Powered
Medical Devices'' may send an email request to<EMAIL_ADDRESS>to receive an electronic copy of the document.
Please use the document number 1400057 to identify the guidance you are
requesting.

IV. Paperwork Reduction Act of 1995

    This draft guidance refers to previously approved collections of
information found in FDA regulations. These collections of information
are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The
collections of information in 21 CFR part 814 have been approved under
OMB control number 0910-0231. The collections of information in 21 CFR
part 807, subpart E have been approved under OMB control number 0910-
0120. The collections of information in 21 CFR part 812 have been
approved under OMB control number 0910-0078. The collections of
information in 21 CFR part 814, subpart H have been approved under OMB
control number 0910-0332. The collections of information in sections
520(m) and 515A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
360j and 21 U.S.C. 360e-1, respectively) and 613(b) of Food and Drug
Administration Safety and Innovation Act have been approved under OMB
control number 0910-0661.

    Dated: October 27, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-27818 Filed 10-30-15; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register: August 18, 2006 (Volume 71, Number 160)]
[Notices]
[Page 47809-47810]
[DOCID:fr18au06-89]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2006-0301; FRL-8077-1]

National Advisory Committee for Acute Exposure Guideline Levels
for Hazardous Substances; Notice of Public Meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: A meeting of the National Advisory Committee for Acute
Exposure Guideline Levels for Hazardous Substances (NAC/AEGL Committee)
will be held from September 6-8, 2006, in Bethesda, MD. At this
meeting, the NAC/AEGL Committee will address, as time permits, the
various aspects of the acute toxicity and the development of Acute
Exposure Guideline Levels (AEGLs) for the following chemicals: 1,2,3-
Trimethylbenzene; 1,2,4-trimethylbenzene; 1,3,5-trimethylbenzene; 2-
ethylhexyl chloroformate; benzyl chloroformate; chlorobenzene;
dibromoethane; ethylbenzene; ethylene oxide; hexafluoropropylene;
phenyl chloroformate; phenyl mercaptan; propargyl alcohol;
tetrafluoroethylene; and trifluorochloroethylene.

DATES: A meeting of the NAC/AEGL Committee will be held from 10 a.m. to
5 p.m. on September 6, 2006, from 8:30 a.m. to 5:30 p.m. on September
7, 2006, and from 8 a.m. to 12:30 p.m. on September 8, 2006.
    For information on access or services for individuals with
disabilities and/or to request accommodation of a disability, please
contact the Designated Federal Officer (DFO) listed under FOR FURTHER
INFORMATION CONTACT at least 10 days prior to the meeting, to give EPA
as much time as possible to process your request.

ADDRESSES: The meeting will be held at the Hyatt Regency Bethesda at
7400 Wisconsin Ave., Bethesda, MD (Bethesda Metro Stop).

FOR FURTHER INFORMATION CONTACT: For general information contact: Colby
Lintner, Regulatory Coordinator, Environmental Assistance Division
(7408M), Office of Pollution Prevention and Toxics, Environmental
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001; telephone number:<PHONE_NUMBER>; e-mail
<EMAIL_ADDRESS>
    For technical information contact: Paul S. Tobin, DFO, Economics,
Exposure, and Technology Division (7406M), Office of Pollution
Prevention and Toxics, 1200 Pennsylvania Ave., NW., Washington, DC
20460-0001; telephone number:<PHONE_NUMBER>; e-mail address:
<EMAIL_ADDRESS>

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    This action is directed to the public in general. This action may
be of particular interest to anyone who may be affected if the AEGL
values are adopted by government agencies for emergency planning,
prevention, or response programs, such as EPA's Risk Management Program
under the Clean Air Act and Amendments Section 112r. It is possible
that other Federal agencies besides EPA, as well as State agencies and
private organizations, may adopt the AEGL values for their programs. As
such, the Agency has not attempted to describe all the specific
entities that may be affected by this action. If you have any questions
regarding the applicability of this action to a particular entity,
consult the DFO listed under FOR FURTHER INFORMATION CONTACT.

B. How Can I Get Copies of this Document and Other Related Information?

    1. Docket. EPA has established a docket for this action under
docket identification (ID) number EPA-HQ-OPPT-2006-0301. Publicly
available docket materials are available electronically at http://www.regulations.gov
 or in hard copy at the OPPT Docket, EPA Docket

Center (EPA/DC), EPA West, Rm. B102, 1301 Constitution Ave., NW.,
Washington, DC. The EPA Docket Center Public Reading Room is open from
8:30 a.m. to 4:30 p.m., Monday through Friday,

excluding legal holidays. The telephone number for the Public Reading
Room is<PHONE_NUMBER>, and the telephone number for the OPPT Docket is
(202) 566-0280.
    2. Electronic access. You may access this Federal Register document
electronically through the EPA Internet under the ``Federal Register''
listings at http://www.epa.gov/fedrgstr/.

II. Meeting Procedures

    For additional information on the scheduled meeting, the agenda of
the NAC/AEGL Committee, or the submission of information on chemicals
to be discussed at the meeting, contact the DFO listed under FOR
FURTHER INFORMATION CONTACT.
    The meeting of the NAC/AEGL Committee will be open to the public.
Oral presentations or statements by interested parties will be limited
to 10 minutes. Interested parties are encouraged to contact the DFO to
schedule presentations before the NAC/AEGL Committee. Since seating for
outside observers may be limited, those wishing to attend the meeting
as observers are also encouraged to contact the DFO at the earliest
possible date to ensure adequate seating arrangements. Inquiries
regarding oral presentations and the submission of written statements
or chemical-specific information should be directed to the DFO.

III. Future Meetings

    Another meeting of the NAC/AEGL Committee is scheduled for December
2006.

List of Subjects

    Environmental protection, Chemicals, Hazardous substances, Health.

    Dated: August 11, 2006.
Charles M. Auer,
Director, Office of Pollution Prevention and Toxics.
[FR Doc. E6-13658 Filed 8-17-06; 8:45 am]

BILLING CODE 6560-50-S


[Federal Register Volume 84, Number 57 (Monday, March 25, 2019)]
[Notices]
[Pages 11116-11117]
[FR Doc No: 2019-05612]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4419-DR; Docket ID FEMA-2019-0001]

Alabama; Major Disaster and Related Determinations

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a notice of the Presidential declaration of a major
disaster for the State of Alabama (FEMA-4419-DR), dated March 5, 2019,
and related determinations.

DATES: The declaration was issued March 5, 2019.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Notice is hereby given that, in a letter
dated March 5, 2019, the President issued a major disaster declaration
under the authority of the Robert T. Stafford Disaster Relief and
Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the ``Stafford
Act''), as follows:

    I have determined that the damage in certain areas of the State
of Alabama resulting from severe storms, straight-line winds, and
tornadoes on March 3, 2019, is of sufficient severity and magnitude
to warrant a major disaster declaration under the Robert T. Stafford
Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121 et seq.
(the ``Stafford Act''). Therefore, I declare that such a major
disaster exists in the State of Alabama.
    In order to provide Federal assistance, you are hereby
authorized to allocate from funds available for these purposes such
amounts as you find necessary for Federal disaster assistance and
administrative expenses.

    You are authorized to provide Individual Assistance and
assistance for debris removal and emergency protective measures
(Categories A and B) under the Public Assistance program in the
designated areas, Hazard Mitigation throughout the State, and any
other forms of assistance under the Stafford Act that you deem
appropriate subject to completion of Preliminary Damage Assessments
(PDAs).
    Consistent with the requirement that Federal assistance is
supplemental, any Federal funds provided under the Stafford Act for
Hazard Mitigation and Other Needs Assistance will be limited to 75
percent of the total eligible costs. Federal funds provided under
the Stafford Act for Public Assistance also will also be limited to
75 percent of the total eligible costs, with the exception of
projects that meet the eligibility criteria for a higher Federal
cost-sharing percentage under the Public Assistance Alternative
Procedures Pilot Program for Debris Removal implemented pursuant to
section 428 of the Stafford Act.
    Further, you are authorized to make changes to this declaration
for the approved assistance to the extent allowable under the
Stafford Act.

    The time period prescribed for the implementation of section
310(a), Priority to Certain Applications for Public Facility and Public
Housing Assistance, 42 U.S.C. 5153, shall be for a period not to exceed
six months after the date of this declaration.
    The Federal Emergency Management Agency (FEMA) hereby gives notice
that pursuant to the authority vested in the Administrator, under
Executive Order 12148, as amended, Gerard M. Stolar, of FEMA is
appointed to act as the Federal Coordinating Officer for this major
disaster.
    The following areas of the State of Alabama have been designated as
adversely affected by this major disaster:

    Lee County for Individual Assistance and assistance for debris
removal and emergency protective measures (Categories A and B) under
the Public Assistance program.
    All areas within the State of Alabama are eligible for
assistance under the Hazard Mitigation Grant Program.
    The following Catalog of Federal Domestic Assistance Numbers
(CFDA) are to be used for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster
Unemployment Assistance (DUA); 97.046, Fire Management Assistance
Grant; 97.048, Disaster Housing Assistance to Individuals and
Households In Presidentially Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance--Disaster Housing
Operations for Individuals and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals and Households--Other
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially
Declared Disasters); 97.039, Hazard Mitigation Grant.

Pete Gaynor,
Acting Administrator, Federal Emergency Management Agency.
[FR Doc. 2019-05612 Filed 3-22-19; 8:45 am]
 BILLING CODE 9111-23-P